High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma
1 clinical trials · Condition
◉ Watch High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy (NCT03345134) | Shaheen Alanee | 2017-11-30 |
Track High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.